Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4307 USD | +0.18% |
|
+21.32% | -42.23% |
07-02 | Traws Pharma Files for Potential Sale of 128.9 Million Shares | MT |
06-21 | Traws Pharma, Inc. Announces Resignation of Steven M. Fruchtman as President and Chief Scientific Officer, Oncology | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-42.23% | 10.88M | |
+27.90% | 46.56B | |
+45.38% | 41.67B | |
+0.24% | 41.16B | |
+32.66% | 32.4B | |
+20.84% | 28.18B | |
-6.35% | 28.1B | |
+48.90% | 14.52B | |
+48.30% | 13.74B | |
+3.15% | 12.17B |
- Stock Market
- Equities
- TRAW Stock
- News Traws Pharma, Inc.
- Transcript : Onconova Therapeutics, Inc. - Shareholder/Analyst Call